Literature DB >> 26901414

Various checkpoints prevent the synthesis of Staphylococcus aureus peptidoglycan hydrolase LytM in the stationary growth phase.

Efthimia Lioliou1, Pierre Fechter1, Isabelle Caldelari1, Brian C Jester2, Sarah Dubrac3, Anne-Catherine Helfer1, Sandrine Boisset4, François Vandenesch4, Pascale Romby1, Thomas Geissmann4.   

Abstract

In Staphylococcus aureus, peptidoglycan metabolism plays a role in the host inflammatory response and pathogenesis. Transcription of the peptidoglycan hydrolases is activated by the essential 2-component system WalKR at low cell density. During stationary growth phase, WalKR is not active and transcription of the peptidoglycan hydrolase genes is repressed. In this work, we studied regulation of expression of the glycylglycine endopeptidase LytM. We show that, in addition to the transcriptional regulation mediated by WalKR, the synthesis of LytM is negatively controlled by a unique mechanism at the stationary growth phase. We have identified 2 different mRNAs encoding lytM, which vary in the length of their 5' untranslated (5'UTR) regions. LytM is predominantly produced from the WalKR-regulated mRNA transcript carrying a short 5'UTR. The lytM mRNA is also transcribed as part of a polycistronic operon with the upstream SA0264 gene and is constitutively expressed. Although SA0264 protein can be synthesized from the longer operon transcript, lytM cannot be translated because its ribosome-binding site is sequestered into a translationally inactive secondary structure. In addition, the effector of the agr system, RNAIII, can inhibit translation of lytM present on the operon without altering the transcript level but does not have an effect on the translation of the upstream gene. We propose that this dual regulation of lytM expression, at the transcriptional and post-transcriptional levels, contributes to prevent cell wall damage during the stationary phase of growth.

Entities:  

Keywords:  Autolysin; LytM; RNAIII; Staphylococcus aureus; cell wall; peptidoglycan; peptidoglycan hydrolase; post-transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 26901414      PMCID: PMC4841606          DOI: 10.1080/15476286.2016.1153209

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  68 in total

1.  ANALYSIS BY TRANSDUCTION OF MUTATIONS AFFECTING PENICILLINASE FORMATION IN STAPHYLOCOCCUS AUREUS.

Authors:  R P NOVICK
Journal:  J Gen Microbiol       Date:  1963-10

Review 2.  The role of peptidoglycan in pathogenesis.

Authors:  Ivo G Boneca
Journal:  Curr Opin Microbiol       Date:  2005-02       Impact factor: 7.934

3.  Inhibition of rot translation by RNAIII, a key feature of agr function.

Authors:  Edward Geisinger; Rajan P Adhikari; Ruzhong Jin; Hope F Ross; Richard P Novick
Journal:  Mol Microbiol       Date:  2006-08       Impact factor: 3.501

4.  Use of targetrons to disrupt essential and nonessential genes in Staphylococcus aureus reveals temperature sensitivity of Ll.LtrB group II intron splicing.

Authors:  Jun Yao; Jin Zhong; Yuan Fang; Edward Geisinger; Richard P Novick; Alan M Lambowitz
Journal:  RNA       Date:  2006-06-01       Impact factor: 4.942

5.  The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response.

Authors:  Aurélia Delauné; Sarah Dubrac; Charlène Blanchet; Olivier Poupel; Ulrike Mäder; Aurélia Hiron; Aurélie Leduc; Catherine Fitting; Pierre Nicolas; Jean-Marc Cavaillon; Minou Adib-Conquy; Tarek Msadek
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

6.  Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII).

Authors:  Jan Oscarsson; Karin Tegmark-Wisell; Staffan Arvidson
Journal:  Int J Med Microbiol       Date:  2006-06-19       Impact factor: 3.473

7.  Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression.

Authors:  Eric Huntzinger; Sandrine Boisset; Cosmin Saveanu; Yvonne Benito; Thomas Geissmann; Abdelkader Namane; Gérard Lina; Jerome Etienne; Bernard Ehresmann; Chantal Ehresmann; Alain Jacquier; François Vandenesch; Pascale Romby
Journal:  EMBO J       Date:  2005-01-27       Impact factor: 11.598

8.  New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria.

Authors:  Maryvonne Arnaud; Arnaud Chastanet; Michel Débarbouillé
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

9.  Global control of cysteine metabolism by CymR in Bacillus subtilis.

Authors:  Sergine Even; Pierre Burguière; Sandrine Auger; Olga Soutourina; Antoine Danchin; Isabelle Martin-Verstraete
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

10.  The expression of LytM is down-regulated by RNAIII in Staphylococcus aureus.

Authors:  Mu Chunhua; Liu Yu; Gao Yaping; Dong Jie; Lu Qiang; Tan Xiaorong; Yang Guang
Journal:  J Basic Microbiol       Date:  2012-05-14       Impact factor: 2.281

View more
  3 in total

1.  The 5' NAD Cap of RNAIII Modulates Toxin Production in Staphylococcus aureus Isolates.

Authors:  Hector Gabriel Morales-Filloy; Yaqing Zhang; Gabriele Nübel; Shilpa Elizabeth George; Natalya Korn; Christiane Wolz; Andres Jäschke
Journal:  J Bacteriol       Date:  2020-02-25       Impact factor: 3.490

2.  Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries.

Authors:  Mithila Rajagopal; Melissa J Martin; Marina Santiago; Wonsik Lee; Veronica N Kos; Tim Meredith; Michael S Gilmore; Suzanne Walker
Journal:  MBio       Date:  2016-08-16       Impact factor: 7.867

3.  The RNA targetome of Staphylococcus aureus non-coding RNA RsaA: impact on cell surface properties and defense mechanisms.

Authors:  Arnaud Tomasini; Karen Moreau; Johana Chicher; Thomas Geissmann; François Vandenesch; Pascale Romby; Stefano Marzi; Isabelle Caldelari
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.